Врахування вітчизняних умов при використанні закордонних Z-моделей прогнозування банкрутства

The green cw laser presented in this work is realized by means of a Pr:YLF crystal emitting at 523 nm that is pumped by a blue GaN laser diode in an extremely short resonator. With a 500 mW-diode a laser has been achieved with M2 = 1, a slope of 40 % and an output power of 140mW with an absorbed pump power of 410 mW which results in an electrooptical efficiency of 6.5 %. Despite the reduced overlap with a 1 W-diode the output power rises to 290 mW with an absorbed pump power of 850 mW and the M2 increases only slightly. Based on these results a compact laser package has been accomplished using a monolithic micro optics for the beam shaping of the diode light and joining all components with a low-shrinkage adhesive on a common base plate. In a first test of the alignment strategy a laser with an output power of 92 mW has been achieved by means of the 500 mW pump power

Fragen des Arbeits-, Tier- und Umweltschutzes bei der Schweinemast in verschiedenen Systemen unter besonderer Berücksichtigung mikrobieller Belastungen

Vor dem Hintergrund häufiger Atemwegserkrankungen bei Schweinen und landwirtschaftlich Beschäftigten war es das Ziel eines interdisziplinären Verbundprojektes, Belastungen von Mensch, Tier und Umwelt in ökologischen und konventionellen Haltungssystemen für die Schweinemast zu erfassen. Die Untersuchungen wurden in zwei konventionellen (Stall A, B) (BVT-Stall, 50% reduzierter Schlitzanteil, Zwangsbelüftung) und zwei ökologischen Ställen durchgeführt: Stall C (Praxisstall: Tiefstreu, freie Fenster-Lüftung), Stall D (Praxisstall: EU-Öko-VO, Trauf-First-Lüftung). Über 2 Mastperioden (je 3 Messungen; kalte / warme Jahreszeit) wurden die Parameter erfasst: luftgetragene Endotoxine, Schimmelpilze, Bakterien mit Differenzierung, arbeitsmedizinische Staubfraktionen, Materialproben, Staubfraktion PM10, NH3, CO2 und CH4, Lufttemperatur, Luftfeuchte. Die Beschreibung der Tiergesundheit erfolgte über serologische (Mycoplasmen, PRRS-, Influenza-A- und Circo-Virus) und koprologische (Parasitenbefall) Analysen und über Schlachtkörper- und Organbefundungen (Lunge, Pleura, Perikard, Leber). Am Beispiel der Endotoxin-Konzentration wurden die z.T. sehr hohen biologischen Belastungen deutlich: Stall C (Median: 14.495 EU/m3), Stall A/B (5.544 EU/m3), Stall D (2.876 EU/m3). Personengetragene Messungen führten zu deutlich höheren Werten. Die CO2- und NH3-Konzentrationen lagen in allen Ställen im Durchschnitt deutlich unter dem Grenzwert von 3000 ppm bzw. 20 ppm. In Stall C und D war die CH4-Konzentration allerdings höher als in Stall A/B (oberer Bereich der Literaturangaben). Auffällige Lungenbefunde fanden sich bei ca. 45% der untersuchten Schlachttiere, unabhängig vom Haltungssystem; parasitäre Leberveränderungen wurden ausschließlich in den Ställen C und D ermittelt. Die Untersuchungsergebnisse unterstreichen die Bedeutung der Ausführung, Dimensionierung und Regelung des Lüftungssystems sowie die Sauberkeit bzw. Hygiene und insbesondere das Betriebsmanagement im Stall und ihre Schlüsselrolle hinsichtlich der Freisetzungsmengen von Schadstoffen sowie der Tiergesundheit. Demgegenüber kommt der Klassifizierung der Haltungsumwelt durch die Einteilung in Haltungssystemen nur eine geringe Aussagekraft zu

Stabilizing sodium hypochlorite at high pH: effects on soft tissue and dentin

NaOH-stabilized NaOCl solutions have a higher alkaline capacity and are thus more proteolytic than standard counterparts

Исследование влияния температуры на процесс восстановления ацетилдифенила изопропилатом алюминия

We present a compact module, emitting nearly diffraction limited green laser light at 531 nm at an average output power of more than 500 mW. As pump source for the second harmonic generation a DBR tapered laser with a total length of 6 mm was used. The RW section had a length of 2 mm including a 1 mm long passive DBR section. The devices were mounted p-side up on a copper block. For this mounting scheme, the device reaches up to 7 W maximal output power. At the power level of about 3.8 W used in the presented experiment, a wavelength of 1062.6 nm with a line-width below 0.02 nm (FWHM) was determined. More than 80% of the emitted power is originated within the central lobe of the beam waist profile illustrating the nearly diffraction limited beam quality. Using a 30mm long MgO-doped periodically poled LiNbO3 bulk crystal, the second harmonic wave is generated in a single-pass setup. Due to precise alignment and beam shaping based on the results of numerical simulations and a properly temperature control of the PPLN crystal, a maximum optical conversion efficiency of more than 14% (3.7%/W) was achieved. The fluctuation of the output power is far below 1%

Multi-minicore Disease

Abstract Multi-minicore Disease (MmD) is a recessively inherited neuromuscular disorder characterized by multiple cores on muscle biopsy and clinical features of a congenital myopathy. Prevalence is unknown. Marked clinical variability corresponds to genetic heterogeneity: the most instantly recognizable classic phenotype characterized by spinal rigidity, early scoliosis and respiratory impairment is due to recessive mutations in the selenoprotein N (SEPN1) gene, whereas recessive mutations in the skeletal muscle ryanodine receptor (RYR1) gene have been associated with a wider range of clinical features comprising external ophthalmoplegia, distal weakness and wasting or predominant hip girdle involvement resembling central core disease (CCD). In the latter forms, there may also be a histopathologic continuum with CCD due to dominant RYR1 mutations, reflecting the common genetic background. Pathogenetic mechanisms of RYR1-related MmD are currently not well understood, but likely to involve altered excitability and/or changes in calcium homeoestasis; calcium-binding motifs within the selenoprotein N protein also suggest a possible role in calcium handling. The diagnosis of MmD is based on the presence of suggestive clinical features and multiple cores on muscle biopsy; muscle MRI may aid genetic testing as patterns of selective muscle involvement are distinct depending on the genetic background. Mutational analysis of the RYR1 or the SEPN1 gene may provide genetic confirmation of the diagnosis. Management is mainly supportive and has to address the risk of marked respiratory impairment in SEPN1-related MmD and the possibility of malignant hyperthermia susceptibility in RYR1-related forms. In the majority of patients, weakness is static or only slowly progressive, with the degree of respiratory impairment being the most important prognostic factor.</p

Altered splicing of the BIN1 muscle-specific exon in humans and dogs with highly progressive centronuclear myopathy

Amphiphysin 2, encoded by BIN1, is a key factor for membrane sensing and remodelling in different cell types. Homozygous BIN1 mutations in ubiquitously expressed exons are associated with autosomal recessive centronuclear myopathy (CNM), a mildly progressive muscle disorder typically showing abnormal nuclear centralization on biopsies. In addition, misregulation of BIN1 splicing partially accounts for the muscle defects in myotonic dystrophy (DM). However, the muscle-specific function of amphiphysin 2 and its pathogenicity in both muscle disorders are not well understood. In this study we identified and characterized the first mutation affecting the splicing of the muscle-specific BIN1 exon 11 in a consanguineous family with rapidly progressive and ultimately fatal centronuclear myopathy. In parallel, we discovered a mutation in the same BIN1 exon 11 acceptor splice site as the genetic cause of the canine Inherited Myopathy of Great Danes (IMGD). Analysis of RNA from patient muscle demonstrated complete skipping of exon 11 and BIN1 constructs without exon 11 were unable to promote membrane tubulation in differentiated myotubes. Comparative immunofluorescence and ultrastructural analyses of patient and canine biopsies revealed common structural defects, emphasizing the importance of amphiphysin 2 in membrane remodelling and maintenance of the skeletal muscle triad. Our data demonstrate that the alteration of the muscle-specific function of amphiphysin 2 is a common pathomechanism for centronuclear myopathy, myotonic dystrophy, and IMGD. The IMGD dog is the first faithful model for human BIN1-related CNM and represents a mammalian model available for preclinical trials of potential therapies

Gain-switched all-fiber laser with narrow bandwidth

Gain-switching of a CW fiber laser is a simple and cost-effective approach to generate pulses using an all-fiber system. We report on the construction of a narrow bandwidth (below 0.1 nm) gain-switched fiber laser and optimize the pulse energy and pulse duration under this constraint. The extracted pulse energy is 20 jiJ in a duration of 135 ns at 7 kHz. The bandwidth increases for a higher pump pulse energy and repetition rate, and this sets the limit of the output pulse energy. A single power amplifier is added to raise the peak power to the kW-level and the pulse energy to 230 ßJ while keeping the bandwidth below 0.1 nm. This allows frequency doubling in a periodically poled lithium tantalate crystal with a reasonable conversion efficiency

Theranostic pretargeted radioimmunotherapy of colorectal cancer xenografts in mice using picomolar affinity 86Y- or 177Lu-DOTA-Bn binding scFv C825/GPA33 IgG bispecific immunoconjugates

Purpose: GPA33 is a colorectal cancer (CRC) antigen with unique retention properties after huA33-mediated tumor targeting. We tested a pretargeted radioimmunotherapy (PRIT) approach for CRC using a tetravalent bispecific antibody with dual specificity for GPA33 tumor antigen and DOTA-Bn–(radiolanthanide metal) complex. Methods: PRIT was optimized in vivo by titrating sequential intravenous doses of huA33-C825, the dextran-based clearing agent, and the C825 haptens [superscript 177]Lu-or [superscript 86]Y-DOTA-Bn in mice bearing the SW1222 subcutaneous (s.c.) CRC xenograft model. Results: Using optimized PRIT, therapeutic indices (TIs) for tumor radiation-absorbed dose of 73 (tumor/blood) and 12 (tumor/kidney) were achieved. Estimated absorbed doses (cGy/MBq) to tumor, blood, liver, spleen, and kidney for single-cycle PRIT were 65.8, 0.9 (TI 73), 6.3 (TI 10), 6.6 (TI 10), and 5.3 (TI 12), respectively. Two cycles of PRIT (66.6 or 111 MBq [superscript 177]Lu-DOTA-Bn) were safe and effective, with a complete response of established s.c. tumors (100 – 700 mm³) in nine of nine mice, with two mice alive without recurrence at >140 days. Tumor log kill in this model was estimated to be 2.1 – 3.0 based on time to 500-mm³ tumor recurrence. In addition, PRIT dosimetry/diagnosis was performed by PET imaging of the positron-emitting DOTA hapten [superscript 86]Y-DOTA-Bn. Conclusion: We have developed anti-GPA33 PRIT as a triplestep theranostic strategy for preclinical detection, dosimetry, and safe targeted radiotherapy of established human colorectal mouse xenografts.National Institute of Mental Health (U.S.) (Grant R01-CA-101830